STOCK TITAN

Therma Bright Inc - TBRIF STOCK NEWS

Welcome to our dedicated page for Therma Bright news (Ticker: TBRIF), a resource for investors and traders seeking the latest updates and insights on Therma Bright stock.

Therma Bright Inc. (TBRIF) is a developer and partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies. The company focuses on providing consumers and medical professionals innovative solutions to address today's most important medical challenges. Therma Bright is traded on TSX Venture Exchange (THRM) and OTCQB (TBRIF). Recent achievements include receiving a cease trade order from the Ontario Securities Commission and working diligently to file required documents. Therma Bright also announced the reopening of its application for Venowave device codes and plans for a strategic review to maximize shareholder value.

Rhea-AI Summary
Therma Bright Inc. announces change of auditors from HS & Partners LLP to Zeifmans LLP. Former Auditor terminated and Successor Auditor appointed effective February 22, 2023. Change of auditor approved by board of directors and audit committee. No reservations or reportable events. Appointment of Successor Auditor to be brought before next shareholders' meeting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Therma Bright Inc. announces amended agreement to acquire 25% interest in InStatin and InVixa, with an option to acquire additional shares. Therma will issue 55,000,000 shares to the Vendors in exchange for shares in InVixa and InStatin. Therma also has the option to purchase more shares in InStatin for up to $499,997.08.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-38.1%
Tags
-
Rhea-AI Summary
Therma Bright Inc. announces partnership with Hero LifeCare for distribution of Venowave device in the U.S.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Therma Bright Inc. submits updated FDA 510K application for Venowave device, aiming to secure permanent CPT and HCPCS codes
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Therma Bright Inc. receives time extension from CMS to secure permanent code for Venowave device
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.23%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.78%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.88%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.52%
Tags
AI
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.37%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.36%
Tags
none

FAQ

What is the current stock price of Therma Bright (TBRIF)?

The current stock price of Therma Bright (TBRIF) is $0.0174 as of February 28, 2025.

What is the market cap of Therma Bright (TBRIF)?

The market cap of Therma Bright (TBRIF) is approximately 12.7M.

What is Therma Bright Inc.?

Therma Bright Inc. is a developer and partner in proprietary diagnostic and medical device technologies.

Where is Therma Bright Inc. traded?

Therma Bright Inc. is traded on the TSX Venture Exchange (THRM) and OTCQB (TBRIF).

What recent achievements has Therma Bright Inc. made?

Recent achievements include receiving a cease trade order from the Ontario Securities Commission and reopening the application for Venowave device codes.

What strategic initiative is Therma Bright Inc. undertaking?

Therma Bright Inc. is initiating a strategic review process to explore alternatives to maximize shareholder value.

What is the focus of Therma Bright Inc.'s technologies?

Therma Bright Inc. focuses on providing consumers and medical professionals with innovative solutions to address important medical challenges.
Therma Bright Inc

OTC:TBRIF

TBRIF Rankings

TBRIF Stock Data

12.74M
422.57M
7.06%
Medical Devices
Healthcare
Link
Canada
Toronto